These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 37737125)

  • 1. EGR1 Promotes Ovarian Hyperstimulation Syndrome Through Upregulation of SOX9 Expression.
    Wang H; Chen W; Huang Y; Sun Y; Liu Y; Zhu Y; Lu Z
    Cell Transplant; 2023; 32():9636897231193073. PubMed ID: 37737125
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tie1 contributes to the development of ovarian hyperstimulation syndrome under the regulation of EGR1 in granulosa cells.
    Sun L; Tian H; Xue S; Ye H; Xue X; Wang R; Liu Y; Zhang C; Chen Q; Gao S
    Exp Mol Med; 2022 Jan; 54(1):81-90. PubMed ID: 35079118
    [TBL] [Abstract][Full Text] [Related]  

  • 3. GnRH Agonist Triggering Modulates PEDF to VEGF Ratio Inversely to hCG in Granulosa Cells.
    Miller I; Chuderland D; Ron-El R; Shalgi R; Ben-Ami I
    J Clin Endocrinol Metab; 2015 Nov; 100(11):E1428-36. PubMed ID: 26308290
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kallistatin prevents ovarian hyperstimulation syndrome by regulating vascular leakage.
    Huang J; Mao Y; Li Q; Hong H; Tang N; Kang X; Huang Y; Liu J; Gong Q; Yao Y; Li L
    J Cell Mol Med; 2022 Aug; 26(16):4613-4623. PubMed ID: 35866203
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human chorionic gonadotropin-induced ovarian hyperstimulation syndrome is associated with up-regulation of vascular endothelial growth factor.
    Wang TH; Horng SG; Chang CL; Wu HM; Tsai YJ; Wang HS; Soong YK
    J Clin Endocrinol Metab; 2002 Jul; 87(7):3300-8. PubMed ID: 12107240
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of gonadotropin-releasing hormone antagonists on the expression of vascular endothelial growth factor and its receptors in a rat model of ovarian hyperstimulation syndrome.
    Tong XM; Zhang SY; Song T; Xu WH; Lin XN; Shu J; Liu L
    Chin Med J (Engl); 2008 Dec; 121(23):2434-9. PubMed ID: 19102964
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of vascular endothelial growth factor and interleukins in the pathogenesis of severe ovarian hyperstimulation syndrome.
    Rizk B; Aboulghar M; Smitz J; Ron-El R
    Hum Reprod Update; 1997; 3(3):255-66. PubMed ID: 9322101
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Upregulation of AREG, EGFR, and HER2 contributes to increased VEGF expression in granulosa cells of patients with OHSS†.
    Fang L; Yu Y; Li Y; Wang S; He J; Zhang R; Sun YP
    Biol Reprod; 2019 Aug; 101(2):426-432. PubMed ID: 31167229
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human chorionic gonadotropin-dependent expression of vascular endothelial growth factor/vascular permeability factor in human granulosa cells: importance in ovarian hyperstimulation syndrome.
    Neulen J; Yan Z; Raczek S; Weindel K; Keck C; Weich HA; Marmé D; Breckwoldt M
    J Clin Endocrinol Metab; 1995 Jun; 80(6):1967-71. PubMed ID: 7775647
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Melatonin stimulates VEGF expression in human granulosa-lutein cells: A potential mechanism for the pathogenesis of ovarian hyperstimulation syndrome.
    Li Y; Fang L; Zhang R; Wang S; Li Y; Yan Y; Yu Y; Cheng JC; Sun YP
    Mol Cell Endocrinol; 2020 Dec; 518():110981. PubMed ID: 32791190
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between LH receptor regulation and ovarian hyperstimulation syndrome in a rodent model.
    Zheng C; Gulappa T; Menon B; Menon KMJ
    Reproduction; 2020 Aug; 160(2):239-245. PubMed ID: 32422603
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vitamin D
    Zhang M; Chen L; Xu Q; Yang X; Liu X; Liu L
    In Vitro Cell Dev Biol Anim; 2024 Apr; 60(4):432-440. PubMed ID: 38573397
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of pigment epithelium-derived factor in the pathophysiology and treatment of ovarian hyperstimulation syndrome in mice.
    Chuderland D; Ben-Ami I; Kaplan-Kraicer R; Grossman H; Ron-El R; Shalgi R
    J Clin Endocrinol Metab; 2013 Feb; 98(2):E258-66. PubMed ID: 23295464
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A potential role of endoplasmic reticulum stress in development of ovarian hyperstimulation syndrome.
    Takahashi N; Harada M; Hirota Y; Zhao L; Yoshino O; Urata Y; Izumi G; Takamura M; Hirata T; Koga K; Wada-Hiraike O; Fujii T; Osuga Y
    Mol Cell Endocrinol; 2016 Jun; 428():161-9. PubMed ID: 27032713
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of IL-6 trans-signaling in vascular leakage: implications for ovarian hyperstimulation syndrome in a murine model.
    Wei LH; Chou CH; Chen MW; Rose-John S; Kuo ML; Chen SU; Yang YS
    J Clin Endocrinol Metab; 2013 Mar; 98(3):E472-84. PubMed ID: 23348396
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intravenous neutralization of vascular endothelial growth factor reduces vascular function/permeability of the ovary and prevents development of OHSS-like symptoms in rhesus monkeys.
    Bishop CV; Lee DM; Slayden OD; Li X
    J Ovarian Res; 2017 Jul; 10(1):41. PubMed ID: 28683759
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Administration of a gonadotropin-releasing hormone agonist affects corpus luteum vascular stability and development and induces luteal apoptosis in a rat model of ovarian hyperstimulation syndrome.
    Scotti L; Irusta G; Abramovich D; Tesone M; Parborell F
    Mol Cell Endocrinol; 2011 Mar; 335(2):116-25. PubMed ID: 21238536
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Organ-specific production control of vascular endothelial growth factor in ovarian hyperstimulation syndrome-model rats.
    Ishikawa K; Ohba T; Tanaka N; Iqbal M; Okamura Y; Okamura H
    Endocr J; 2003 Oct; 50(5):515-25. PubMed ID: 14614207
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dopamine receptor 2 activation inhibits ovarian vascular endothelial growth factor secretion in an ovarian hyperstimulation syndrome (OHSS) animal model: implications for treatment of OHSS with dopamine receptor 2 agonists.
    Ferrero H; García-Pascual CM; Gaytán M; Morales C; Simón C; Gaytán F; Pellicer A; Gómez R
    Fertil Steril; 2014 Nov; 102(5):1468-1476.e1. PubMed ID: 25217874
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Zinc finger gene 217 (ZNF217) Promoted Ovarian Hyperstimulation Syndrome (OHSS) through Regulating E
    Zhai J; Liu J; Cheng X; Li S; Hong Y; Sun K; Chen ZJ; Du Y; Li W
    Sci Rep; 2017 Jun; 7(1):3245. PubMed ID: 28607476
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.